Publication | Open Access

Time-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s disease

Refractory Hodgkin ’Lymphoid NeoplasiaLow ToxicityClinical TherapeuticMedicinePharmacotherapyTime-intensified Dexamethasone/cisplatin/cytarabineCancer TreatmentOncologyRadiation Oncology